2024-11-10 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a leading developer and manufacturer of robotic surgical systems, primarily focused on minimally invasive procedures.

**Performance Analysis:**

**1. Return vs S&P 500:**

* **Cumulative Return (ISRG):** 378.28%
* **Cumulative Return (VOO):** 141.71%
* **Return Difference:** 236.57% 
* **Relative Outperformance:** 81.51% (indicating ISRG's performance is currently above the 81.51 percentile of its historical performance range compared to the S&P 500).

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|----------|-----|-------|
| 2015-2017 | 108.3% | 16.7% | 78.1% | 0.8 |
| 2016-2018 | 162.5% | 23.9% | 137.8% | 1.2 |
| 2017-2019 | 176.3% | 23.9% | 133.2% | 1.4 |
| 2018-2020 | 118.0% | 40.4% | 78.9% | 1.2 |
| 2019-2021 | 131.3% | 40.4% | 41.5% | 1.2 |
| 2020-2022 | 33.3% | 45.8% | 15.6% | 1.2 |
| 2021-2023 | 26.5% | 45.8% | -2.3% | 1.4 |
| 2022-2024 | 45.6% | 45.1% | 21.0% | 1.3 |

* **Analysis:**  ISRG consistently outperforms the S&P 500 with high Alpha values, indicating strong stock-specific performance. Beta fluctuates between 0.8 and 1.4, suggesting moderate to slightly above average market sensitivity.

**2. Recent Price Movement:**

* **Closing Price:** 524.28 (Last-market: 536.58)
* **5-day Moving Average:** 513.75
* **20-day Moving Average:** 505.39
* **60-day Moving Average:** 491.32

* **Analysis:** The current price is slightly above the 5-day and 20-day moving averages, suggesting potential short-term upward momentum. The stock is trading above all three moving averages, indicating an overall positive trend.

**3. Technical Indicators:**

* **RSI:** 53.22 (Neutral)
* **PPO:** 0.1 (Positive)
* **Delta_Previous_Relative_Divergence:** 7.51 (+) (Short-term upward movement)
* **Expected Return:** 12.6% (Long-term expected outperformance over S&P 500)

* **Analysis:** Technical indicators are currently showing mixed signals. RSI indicates a neutral level, while PPO suggests positive momentum. The positive Delta_Previous_Relative_Divergence indicates a potential short-term upward trend. However, considering the recent price movement, the 536.58 Last-market price might indicate a possible correction or consolidation phase.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-18 | 1.59 | $2.04 B$ |
| 2024-07-19 | 1.48 | $2.01 B$ |
| 2024-04-19 | 1.54 | $1.89 B$ |
| 2023-10-20 | 1.18 | $1.74 B$ |
| 2024-10-18 | 1.18 | $1.74 B$ |

* **Analysis:** ISRG has shown steady revenue growth and strong profitability in recent quarters. The most recent earnings report for Q3 2024 exceeded analyst expectations, with EPS reaching $1.59 compared to the expected $1.47. The company continues to benefit from the growing demand for minimally invasive surgical procedures.

**5. Financial Information:**

* **Revenue and Profitability:**  Revenue and profitability are both consistently strong, showing consistent growth over the last year. Profit Margin remains stable and high, indicating efficient operations and strong pricing power.
* **Capital and Profitability:**  Equity is increasing, and ROE is stable around 3.5%, showing the company's ability to generate solid returns on invested capital.

**6. News and Recent Issues:**

* **Recent Earnings Release:** On October 18, 2024, Intuitive Surgical released its Q3 2024 earnings report, exceeding analyst expectations. This positive report was well received by the market, potentially contributing to the recent price movement.
* **Market Outlook:**  Several analysts maintain positive outlook on ISRG, citing its strong market position, growing demand for minimally invasive procedures, and its commitment to innovation. Some analysts note potential headwinds, including increasing competition and regulatory challenges, but overall remain optimistic about the long-term growth prospects of the company.
* **Analyst Opinions:**  Many analysts have a "Buy" or "Strong Buy" rating on ISRG. FINBOLD reports a "Strong Buy" rating with a consensus price target of $575.29, indicating a potential upside of over 10%.

**7. Overall Analysis:**

Intuitive Surgical exhibits strong fundamental performance, evidenced by consistent revenue growth, high profitability, and positive market sentiment.  While recent price movements might suggest potential for consolidation, the long-term outlook remains positive, supported by strong technical indicators and favorable analyst opinions. The stock's strong Alpha and long-term expected return indicate potential for outperformance over the S&P 500. However, investors should remain aware of potential risks associated with the industry, such as increasing competition and regulatory challenges.

**Recommendations:** 

* **Long-term investors:** ISRG remains a solid long-term investment option, with the potential for significant growth.
* **Short-term traders:**  Consider waiting for a pullback in the price before entering a position, but be aware of potential price volatility.

**Disclaimer:** This report is for informational purposes only and does not constitute investment advice. Always consult with a qualified financial advisor before making any investment decisions.
